BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19399189)

  • 21. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma.
    Husain H; Psyrri A; Markovic A; Rampias T; Pectasides E; Wang H; Slebos R; Yarbrough WG; Burtness B; Chung CH
    Laryngoscope; 2012 Dec; 122(12):2762-8. PubMed ID: 23086695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck.
    Odar K; Boštjančič E; Gale N; Glavač D; Zidar N
    Histopathology; 2012 Aug; 61(2):257-65. PubMed ID: 22690848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.
    Uehara T; Kanazawa T; Mizukami H; Uchibori R; Tsukahara T; Urabe M; Kume A; Misawa K; Carey TE; Suzuki M; Ichimura K; Ozawa K
    Cancer Sci; 2014 Jan; 105(1):72-80. PubMed ID: 24168112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PHF21B as a candidate tumor suppressor gene in head and neck squamous cell carcinomas.
    Bertonha FB; Barros Filho Mde C; Kuasne H; Dos Reis PP; da Costa Prando E; Muñoz JJ; Roffé M; Hajj GN; Kowalski LP; Rainho CA; Rogatto SR
    Mol Oncol; 2015 Feb; 9(2):450-62. PubMed ID: 25454821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.
    Rahman MA; Amin AR; Wang D; Koenig L; Nannapaneni S; Chen Z; Wang Z; Sica G; Deng X; Chen ZG; Shin DM
    Clin Cancer Res; 2013 Jul; 19(13):3416-28. PubMed ID: 23719266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
    Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
    Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
    Faridoni-Laurens L; Bosq J; Janot F; Vayssade M; Le Bihan ML; Kaghad M; Caput D; Bénard J; Ahomadegbe JC
    Oncogene; 2001 Aug; 20(38):5302-12. PubMed ID: 11536043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
    Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
    Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.
    Prince ME; Sivanandan R; Kaczorowski A; Wolf GT; Kaplan MJ; Dalerba P; Weissman IL; Clarke MF; Ailles LE
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):973-8. PubMed ID: 17210912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
    Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
    Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma.
    Lemaire F; Millon R; Muller D; Rabouel Y; Bracco L; Abecassis J; Wasylyk B
    Br J Cancer; 2004 Jul; 91(2):258-61. PubMed ID: 15213722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma.
    Pedrero JM; Carracedo DG; Pinto CM; Zapatero AH; Rodrigo JP; Nieto CS; Gonzalez MV
    Int J Cancer; 2005 Mar; 114(2):242-8. PubMed ID: 15543611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis.
    Hauser B; Zhao Y; Pang X; Ling Z; Myers E; Wang P; Califano J; Gu X
    PLoS One; 2015; 10(3):e0116321. PubMed ID: 25764126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
    Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
    Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of gefitinib effectiveness in a broad panel of head and neck squamous carcinoma cells.
    Sebastian S; Azzariti A; Accardi R; Conti D; Pilato B; LaCalamita R; Porcelli L; Simone GM; Tommasi S; Tommasino M; Paradiso A
    Int J Mol Med; 2008 Jun; 21(6):809-17. PubMed ID: 18506376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
    Waseem A; Ali M; Odell EW; Fortune F; Teh MT
    Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.